drugset / Trial / NCT02832947
PK of Rivaroxaban in Bariatric Patients - Extension
Phase 1
Completed
13 enrolled
Insel Gruppe AG, University Hospital Bern
University of Lausanne Hospitals · collab
NaSingle-groupOpen-labelPrevention
Summary
Aim of this clinical Trial is the assessment of rivaroxaban PK/PD parameters in patients 6-8 months after bariatric surgery
Timeline
- Start
- 2016-02
- Primary completion
- 2016-06
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivaroxaban | Other / unclassified | 10 mg | — |